|

NEU-411 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Neuron23 Inc.1

Indications

  • Early Parkinson Disease (Early PD)1
  • Idiopathic Parkinson Disease1
  • Parkinson Disease, Idiopathic1
  • Parkinson's Disease1
  • Parkinson1

Sun City, Arizona1 trial

A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

Banner Sun Health Research Institute

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.